Skip to main content

Table 2 Serum levels of anti-CFFCP and anti-CCP2 antibodies in the sera of RA and non-RA populations with values above the cut-off point

From: Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

  

CFFCP1

CFFCP2

CFFCP3

CCP2

 

n

No. positive

Mean (Std)

No. positive

Mean (Std)

No. positive

Mean (Std)

No. positive

Mean (Std)

RA

322

232

1.58 (1)

251

1.61 (1.08)

230

1.70 (1.04)

238

842 (605)

SLE

119

11

0.73 (0.86)

11

0.78 (0.86)

9

0.95 (1.11)

9

205 (305)

HCV

84

12

0.34 (0.08)

2

0.66 (0.08)

2

0.41 (0.05)

1

46

PsA

133

6

0.52 (0.41)

13

0.39 (0.38)

2

1 (0.61)

4

120 (84)

BD

307

6

0.66 (0.45)

6

0.59 (0.45)

6

0.72 (0.52)

6

67 (37)

  1. No = total number of patients; No. positive = number of positive patients; Std = standard deviation. Statistical differences were observed between RA and non-RA serum levels (P < 0.001).